Keith Merker Resigns As CEO, Director Of WeedMD

WeedMD Inc (TSXV: WMD) announced this morning that Keith Merker has stepped down as a director as well as Chief Executive Officer of the firm effectively immediately. The announcement follows the current trend in the cannabis space as founders and early management teams are being replaced in favour of more seasoned executives.

Taking Merker’s place as Chief Executive Officer is that of Angelo Tsebelis, the current President of WeedMD and the former President of Starseed Holdings. Tsebelis came to the firm as a result of the $78 million all stock transaction that saw WeedMD acquire Starseed late last year.

That transaction, which was largely predicated on Starseed’s sales channel through the Laborers’ Inernational Union of North America (LiUNA) Local 138, as well as a $25 million cash injection by that of LiUNA has to date not been received well by the market. At the time of announcement, WeedMD was publicly valued at roughly $106 million, which included two licensed facilities, 27 acres of outdoor production, and a dedicated extraction center. Comparatively, Starseed largely had a large sales channel through LiUNA, and a single facility that it purchased from Canopy Growth located in Bowmanville, with most product that was sold being sourced via wholesale suppliers.

Tsebelis has a track record of close to two decades worth of commercial experience in the pharmaceutical and healthcare industries. Previous work experienced includes that of Shoppers Drug Mart and Loblaw Corporation where he served as director of commercial partnerships. Prior to this, he spent time at GlaxoSmithKline in the sales department. Most recently, he was responsible for strategic commercialization and product development initiatives for WeedMD and Starseed.

WeedMD is perfectly positioned to move into the next phase of growth and I’m honoured to be taking the reins as we steer towards fully monetizing our distribution channels. I’m looking forward to working closely with the integrated team, our partners, patients and stakeholders to accelerate our commercial growth and business development initiatives.

Angelo Tsebelis, CEO of WeedMD

WeedMD last traded at $0.79 on the TSX Venture.


Information for this analysis was found via Sedar, and WeedMD Inc. The author has no securities related to this organization. WeedMD Inc was previously a client of CanaCom Group, the parent company of The Deep Dive. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Avino Q2 Earnings: Steady As She Goes

MEG Energy: Cenovus Comes In With $7.9 BILLION Offer

Orla Mining Q2 Earnings: Musselwhite Changes Everything

Recommended

Northern Superior Expands Philibert With 350 Metre Step Out Testing 1.10 g/t Gold Over 25.5 Metres

Goliath Resources Hits 18.58 g/t Gold Over 5.00 Metres At Surebet

Related News

WeedMD Responds To UFCW Notice To Bargain

WeedMD Inc (TSXV: WMD) this morning elected to publicly respond to the prior notice to...

Friday, March 27, 2020, 08:53:27 AM

Drug Trade: The Three Basic Cannabis Health Company Archetypes

The popular belief that cannabis will work its way further into mainstream culture and further...

Saturday, December 21, 2019, 08:00:00 AM

WeedMD Announces Preliminary Second Quarter Revenues Beating Analyst Estimates

WeedMD Inc (TSXV: WMD) provided preliminary guidance for their second quarter financials of 2019 this...

Wednesday, August 7, 2019, 09:31:42 AM

WeedMD Posts Q1 2021 Revenues Of $10.3 Million, Net Loss Of $7.0 Million

WeedMD (TSXV: WMD) this morning reported its first quarter 2021 financial results, posting revenues of...

Tuesday, June 29, 2021, 07:41:04 AM

Outdoor Cannabis Cultivation Has Arrived in Canada

Outdoor grow is coming to Canada in a hurry. Health Canada, the regulating body for...

Monday, June 3, 2019, 07:00:53 AM